175 related articles for article (PubMed ID: 32356244)
41. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
42. Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment.
Ercalik NY; Yenerel NM; Imamoglu S; Kumral ET; Vural ET
J Ocul Pharmacol Ther; 2016 May; 32(4):225-9. PubMed ID: 27092435
[TBL] [Abstract][Full Text] [Related]
43. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
[TBL] [Abstract][Full Text] [Related]
44. Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH).
Spiteri Cornish K; Lois N; Scott N; Burr J; Cook J; Boachie C; Tadayoni R; la Cour M; Christensen U; Kwok A
Cochrane Database Syst Rev; 2013 Jun; (6):CD009306. PubMed ID: 23740611
[TBL] [Abstract][Full Text] [Related]
45. Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema.
Kolacny D; Parys-Vanginderdeuren R; Van Lommel A; Stalmans P
Bull Soc Belge Ophtalmol; 2005; (296):15-23. PubMed ID: 16050416
[TBL] [Abstract][Full Text] [Related]
46. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
[TBL] [Abstract][Full Text] [Related]
47. Efficacy comparison of intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy.
Lu Q; Lu L; Chen B; Chen W; Lu P
Can J Ophthalmol; 2019 Jun; 54(3):291-296. PubMed ID: 31109466
[TBL] [Abstract][Full Text] [Related]
48. Outcomes of vitrectomy, membranectomy and internal limiting membrane peeling in patients with refractory diabetic macular edema and non-tractional epiretinal membrane.
Ghassemi F; Bazvand F; Roohipoor R; Yaseri M; Hassanpoor N; Zarei M
J Curr Ophthalmol; 2016 Dec; 28(4):199-205. PubMed ID: 27830204
[TBL] [Abstract][Full Text] [Related]
49. Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema.
Mochizuki Y; Hata Y; Enaida H; Yoshiyama K; Miyazaki M; Ueno A; Murata T; Sakamoto T; Kubota T; Ishibashi T
Retina; 2006 Feb; 26(2):143-8. PubMed ID: 16467668
[TBL] [Abstract][Full Text] [Related]
50. The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.
Yan Y; Zhu L; Hong L; Deng J; Song Y; Chen X
Acta Ophthalmol; 2016 Jun; 94(4):358-64. PubMed ID: 26285163
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the effect of ranibizumab and dexamethasone implant on serous retinal detachment in diabetic macular edema.
Demircan A; Ozkaya A; Alkin Z; Kemer B; Yesilkaya C; Demir G
J Fr Ophtalmol; 2018 Oct; 41(8):733-738. PubMed ID: 30213609
[TBL] [Abstract][Full Text] [Related]
52. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
Fan C; Wang Y; Ji Q; Zhao B; Xie J
Curr Eye Res; 2014 Sep; 39(9):938-43. PubMed ID: 24635755
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy.
Someya H; Takayama K; Takeuchi M; Yokoyama H; Kimura T; Morioka M; Takamura Y; Sameshima S; Ueda T; Ogata N; Tashiro M; Kitano S; Sakamoto T
J Ophthalmol; 2019; 2019():5304524. PubMed ID: 31885887
[TBL] [Abstract][Full Text] [Related]
54. [Vitrectomy without internal limiting membrane peeling associated with gas tamponade for treatment of foveoschisis in pathologic myopia].
Zhang YP; Xue AQ; Wang YQ; Yan WT; Song ZM
Zhonghua Yan Ke Za Zhi; 2011 Jun; 47(6):497-503. PubMed ID: 21914263
[TBL] [Abstract][Full Text] [Related]
55. Dexamethasone implant as an adjuvant therapy to ranibizumab loading dose in persistent diabetic macular edema.
Cakir A; Erden B; Bolukbasi S; Bayat AH; Ozturan SG; Elcioglu MN
Int Ophthalmol; 2019 Oct; 39(10):2179-2185. PubMed ID: 30470985
[TBL] [Abstract][Full Text] [Related]
56. The role of ILM peeling in vitreous surgery for proliferative diabetic retinopathy complications.
Michalewska Z; Bednarski M; Michalewski J; Jerzy N
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(3):238-42. PubMed ID: 23676224
[TBL] [Abstract][Full Text] [Related]
57. Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: a pilot study.
Liang XL; Chen HY; Huang YS; Au Eong KG; Yu SS; Liu X; Yan H
Ann Acad Med Singap; 2007 Apr; 36(4):293-7. PubMed ID: 17483861
[TBL] [Abstract][Full Text] [Related]
58. Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema.
Bahadir M; Ertan A; Mertoğlu O
Int Ophthalmol; 2005; 26(1-2):3-8. PubMed ID: 16786177
[TBL] [Abstract][Full Text] [Related]
59. Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema.
Ulrich JN
Open Ophthalmol J; 2017; 11():5-10. PubMed ID: 28567164
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of vitrectomy and internal limiting membrane removal for macular edema associated with branch retinal vein occlusion.
Arai M; Yamamoto S; Mitamura Y; Sato E; Sugawara T; Mizunoya S
Ophthalmologica; 2009; 223(3):172-6. PubMed ID: 19174614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
